




















Dietary restriction (DR) has been shown to robustly 
modulate organismal lifespan in multiple species. The 
powerful genetic tools in yeast, worms and flies hold 
great promise in unraveling the secrets of the molecular 
mechanisms of this process that have been elusive for 
more than seven decades, since DR was first described 
to extend lifespan in mice. In a recent study, Carrano 
and colleagues report the discovery that an E2/E3 
ubiquitin ligase set are required for the lifespan 
extending effects of DR in C.elegans [1].  
 
The authors utilize C. elegans to look at E3 ubiquitin 
ligases of the conserved HECT (Homologous to E6-AP 
Carboxyl Terminus) family known to be important in 
tumorigenesis in mammals [2]. C. elegans contains a 
single ortholog of the WW class of HECT E3s known 
as WWP-1. Mutant analysis revealed that the C. elegans 
gene is required for embryonic development but that 
weak mutants or naïve adults exposed to wwp-1 dsRNA 
have wildtype lifespan under normal culture conditions 
but are sensitive to heat and oxidative stress. Stress 
response genes are often involved in modulating normal 
lifespan in a positive manner. Consistent with this 
notion the authors find that overexpression of wwp-1 
leads to a lengthened lifespan in otherwise wildtype 
animals. As these results implicate WWP-1 as having 
both a stress resistance and pro-longevity function the 
authors next test whether the gene contributes to other 
known longevity pathways.  
 
Insulin/IGF signaling, mitochondrial function and 
nutrients control distinct aspects of C. elegans lifespan. 























vity pathways, the authors examine mutant 
combinations with essential components of these path-
ways. They find that a loss of wwp-1 in long lived 
insulin/IGF and mitochondrial mutants results in a 
modest shortening of their extended lifespan. However, 
the lifespan extension in eat-2 mutants, which eat less 
due to reduced pharyngeal pumping rate and are 
therefore under DR, is abrogated. They also convincing-
ly show that WWP-1 is involved in DR by using a 
method that utilizes bacterial dilution to impart lifespan 
extension. One of the dramatic findings was that the 3 
fold extension of lifespan achieved by reducing food 
concentration in liquid culture is almost entirely 
suppressed by a loss of wwp-1. These experiments 
genetically implicate WWP-1 as being a key player in 
the DR pathways of longevity.  
 
WWP-1 is orthologous to mammalian E3 ubiquitin 
ligases and the authors show biochemically, that WWP-
1 also has E3 activity in vitro. Disruption of a key 
residue in the catalytic domain abolished both the in 
vitro activity and its ability to rescue the DR phenotype. 
As part of the ubiquitin targeting process E3s function 
in a cascade that has  immediately upstream of it an E2 
ubiquitin conjugating enzyme, WWP-1 had previously 
been found to interact with a specific E2 ubiquitin 
conjugating enzyme known as UBC-18 [3]. The authors 
find from their in vitro assay that most of the functional 
E3 activity of WWP-1 is dependent on the presence of 
UBC-18. Furthermore, they show that the two proteins 
(UBC-18 and WWP-1) interact in a GST pull down 
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for DR induced lifespan extension.  
 
An understanding of the molecular pathways that 
mediate the protective effects of DR is one of the most 
important questions in biomedicine. Previous studies in 
C. elegans have identified novel genetic pathways that 
determine the beneficial effects of DR [4,5,6,7,8]. Key 
regulators of DR-dependent lifespan extension include 
transcription factors and environmental sensors such as 
PHA-4, SKN-1, HSF-1, and AMPK, which were 
identified by different dietary regimens that restrict 
nutrient intake. TOR (Target of Rapamycin) is also 
emerging as a key regulator in mediating the effects of 
DR and is conserved across species. It is has been 
shown to modulate lifespan extension in flies [9], yeast 
[10], worms [11] and most recently mice [12]. The 
signaling pathways that mediate the effects of DR are 
complex and impinge on a variety of cellular targets. 
For example, the TOR pathway was recently shown to 
modulate the effects of DR in C. elegans through HIF-1 
acting downstream of S6K to modulate DR-dependent 
lifespan extension via the IRE-1 ER stress pathway 
[13]. It is now becoming apparent that the maximal 
lifespan extension by DR is not achieved by regulating 
a single genetic pathway but that multiple pathways act 
together to mediate the lifespan effect of DR. Future 
research examining how the E2/E3 ligase set identified 
by Carrano and colleagues interacts with other path-
ways of DR in C. elegans will be of great interest. 
Importantly the E2/E3 ligase set likely functions to 
degrade or modulate a target protein(s) whose non-
ubiquitinated function shortens lifespan in stressful 
conditions such as low nutrient availability and high 
temperature. Identification of the upstream signaling 
cascades that activate this E2/E3 ligase set and their 
specific targets should yield a better understanding of 
how animals modulate their lifespan based on 
environmental conditions such as nutrient availability. 
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